Why is Pfizer adding this new requirement for patients enrolled in a Medicare Part D/Medicare Advantage Plan in 2025?

The 2025 benefit changes outlined in the Inflation Reduction Act will help many Medicare Part D/Medicare Advantage patients, including (1) the reduction of out-of-pocket prescription costs for covered medicines to $2,000 annually and (2) a voluntary option for enrollment in the Medicare Prescription Payment Plan.